458 related articles for article (PubMed ID: 9135122)
21. Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions.
Zhou GP; Troy FA
Glycobiology; 2003 Feb; 13(2):51-71. PubMed ID: 12626407
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
23. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
[TBL] [Abstract][Full Text] [Related]
24. Solution structure of Grb2 reveals extensive flexibility necessary for target recognition.
Yuzawa S; Yokochi M; Hatanaka H; Ogura K; Kataoka M; Miura K; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 2001 Feb; 306(3):527-37. PubMed ID: 11178911
[TBL] [Abstract][Full Text] [Related]
25. 1H- and 13C-NMR investigations on cis-trans isomerization of proline peptide bonds and conformation of aromatic side chains in H-Trp-(Pro)n-Tyr-OH peptides.
Poznański J; Ejchart A; Wierzchowski KL; Ciurak M
Biopolymers; 1993 May; 33(5):781-95. PubMed ID: 8393714
[TBL] [Abstract][Full Text] [Related]
26. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
28. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
29. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
[TBL] [Abstract][Full Text] [Related]
30. Exploring the limits of precision and accuracy of protein structures determined by nuclear magnetic resonance spectroscopy.
Clore GM; Robien MA; Gronenborn AM
J Mol Biol; 1993 May; 231(1):82-102. PubMed ID: 8496968
[TBL] [Abstract][Full Text] [Related]
31. Internal mobility of reactive-site-hydrolyzed recombinant Cucurbita maxima trypsin inhibitor-V characterized by NMR spectroscopy: evidence for differential stabilization of newly formed C- and N-termini.
Liu J; Prakash O; Huang Y; Wen L; Wen JJ; Huang JK; Krishnamoorthi R
Biochemistry; 1996 Sep; 35(38):12503-10. PubMed ID: 8823186
[TBL] [Abstract][Full Text] [Related]
32. Calculation of ensembles of structures representing the unfolded state of an SH3 domain.
Choy WY; Forman-Kay JD
J Mol Biol; 2001 May; 308(5):1011-32. PubMed ID: 11352588
[TBL] [Abstract][Full Text] [Related]
33. Modelling of the complex between a 15-residue peptide from mSos2 and the N-terminal SH3 domain of Grb2 by molecular-dynamics simulation.
Calero S; Lago S; van Gunsteren WF; Daura X
Chem Biodivers; 2004 Mar; 1(3):505-19. PubMed ID: 17191865
[TBL] [Abstract][Full Text] [Related]
34. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
35. Solution structure of the 30 kDa N-terminal domain of enzyme I of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system by multidimensional NMR.
Garrett DS; Seok YJ; Liao DI; Peterkofsky A; Gronenborn AM; Clore GM
Biochemistry; 1997 Mar; 36(9):2517-30. PubMed ID: 9054557
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of Syrian hamster prion protein rPrP(90-231).
Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
[TBL] [Abstract][Full Text] [Related]
37. Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation.
Hoang HN; Bryant GK; Kelso MJ; Beyer RL; Appleton TG; Fairlie DP
Inorg Chem; 2008 Oct; 47(20):9439-49. PubMed ID: 18788796
[TBL] [Abstract][Full Text] [Related]
38. NMR studies of unfolded states of an SH3 domain in aqueous solution and denaturing conditions.
Zhang O; Forman-Kay JD
Biochemistry; 1997 Apr; 36(13):3959-70. PubMed ID: 9092826
[TBL] [Abstract][Full Text] [Related]
39. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
40. Refined solution structure and backbone dynamics of HIV-1 Nef.
Grzesiek S; Bax A; Hu JS; Kaufman J; Palmer I; Stahl SJ; Tjandra N; Wingfield PT
Protein Sci; 1997 Jun; 6(6):1248-63. PubMed ID: 9194185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
